N
New Health Sciences
New Health Sciences develops a technology to extend the shelf life of refrigerated red blood cells using novel storage methods
About New Health Sciences
Hemanext is dedicated to revolutionizing patient care through the development and commercialization of advanced technologies in transfusion medicine. The company focuses on improving the safety and efficacy of blood transfusions, a critical component of modern healthcare systems. Hemanext's primary clients include hospitals, blood banks, and healthcare providers who require reliable and effective blood transfusion solutions. Operating in the medical technology market, Hemanext employs a business model centered around the acquisition, development, and sale of innovative transfusion products. Revenue is generated through the commercialization of these technologies, which aim to enhance the oxygen-carrying capacity of transfused blood and reduce the adverse effects associated with refrigerated blood storage.
Source: Dealroom company dataAt a glance
- Founded
- 2000
- Headquarters
- Lexington, United States
- Sector
- Biotech & Life Sciences
News
Open roles
New Health Sciences in the Lexington ecosystem
The New Health Sciences office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
National Institutes of Health
Omega Advisors
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about New Health Sciences on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See New Health Sciences on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.
